MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in MoonLake Immunotherapeutics as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +10 vs. Q4 2022
- Shares held
- 39.4M
- +1.67M (+4.4%) vs. Q4 2022
- Total value
- $843.2M
- +$446.8M (+112.7%) vs. Q4 2022
- New holders
- 21
- 11 more added
- Sold out
- 11
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 21,751,284 | $465.3M | 17.01% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 6,892,101 | $147.4M | 9.71% | +827,100+13.6% | Added |
| Citadel Advisors LLC | 2,923,438 | $62.5M | 0.07% | +37,346+1.3% | Added |
| Adage Capital Partners GP, L.L.C. | 1,668,871 | $35.7M | 0.08% | +1,668,871 | New |
| Polar Capital Holdings Plc | 876,377 | $18.7M | 0.14% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 830,906 | $17.8M | 0.00% | +8,305+1.0% | Added |
| Federated Hermes, Inc. | 804,499 | $17.2M | 0.04% | +804,499 | New |
| RTW Investments, LP | 500,000 | $10.7M | 0.22% | 00.0% | Unchanged |
| FMR LLC | 475,432 | $10.2M | 0.00% | +289,932+156.3% | Added |
| JPMorgan Chase & Co | 303,222 | $6.49M | 0.00% | +258,378+576.2% | Added |
| AXA S.A. | 301,354 | $6.45M | 0.02% | −103,930−25.6% | Reduced |
| Great Point Partners LLC | 278,334 | $5.95M | 1.18% | −364,232−56.7% | Reduced |
| Balyasny Asset Management LLC | 197,707 | $4.23M | 0.01% | −20,292−9.3% | Reduced |
| Ghost Tree Capital, LLC | 195,000 | $4.17M | 1.58% | +195,000 | New |
| Invesco Ltd. | 176,770 | $3.78M | 0.00% | +176,770 | New |
| HighVista Strategies LLC | 122,201 | $2.61M | 2.13% | +122,201 | New |
| BlackRock Inc. | 114,930 | $2.46M | 0.00% | −626,828−84.5% | Reduced |
| Fred Alger Management, LLC | 106,920 | $2.29M | 0.01% | +106,920 | New |
| Silverarc Capital Management, LLC | 105,750 | $2.26M | 1.02% | +105,750 | New |
| Citigroup Inc | 77,276 | $1.65M | 0.00% | −89,041−53.5% | Reduced |
| Granahan Investment Management Inc | 73,637 | $1.58M | 0.05% | +73,637 | New |
| Ally Bridge Group (NY) LLC | 72,850 | $1.56M | 2.04% | +72,850 | New |
| Jefferies Financial Group Inc. | 69,713 | $1.49M | 0.03% | +2,059+3.0% | Added |
| TD Asset Management Inc | 67,312 | $1.44M | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 59,858 | $1.28M | 0.01% | +59,858 | New |
| Manufacturers Life Insurance Company, The | 48,550 | $1.04M | 0.00% | +48,550 | New |
| 5AM Venture Management, LLC | 38,856 | $831.1K | 0.21% | +38,856 | New |
| Schonfeld Strategic Advisors LLC | 37,200 | $795.7K | 0.01% | +37,200 | New |
| Millennium Management LLC | 35,071 | $750.0K | 0.00% | +35,071 | New |
| Morgan Stanley | 32,519 | $695.6K | 0.00% | +5,154+18.8% | Added |
| Point72 Asset Management, L.P. | 29,748 | $636.3K | 0.00% | +29,748 | New |
| Jane Street Group, LLC | 26,034 | $556.9K | 0.00% | +26,034 | New |
| Velan Capital Investment Management LP | 23,400 | $500.5K | 0.44% | +23,400 | New |
| Renaissance Technologies LLC | 22,700 | $486.0K | 0.00% | +11,091+95.5% | Added |
| Geode Capital Management, LLC | 17,109 | $366.0K | 0.00% | +5,658+49.4% | Added |
| SVB Financial Group | 16,173 | $345.9K | 0.66% | 00.0% | Unchanged |
| Boulder Hill Capital Management LP | 14,500 | $310.2K | 0.25% | +14,500 | New |
| Ensign Peak Advisors, Inc | 11,575 | $247.6K | 0.00% | +11,575 | New |
| Bank of America Corp | 10,280 | $219.9K | 0.00% | +2,380+30.1% | Added |
| UBS Group AG | 7,960 | $170.3K | 0.00% | −65,428−89.2% | Reduced |
| Dorsey Wright & Associates | 1,000 | $21.4K | 0.01% | +1,000 | New |
| Royal Bank of Canada | 656 | $14.0K | 0.00% | +580+763.2% | Added |
| Advisor Group Holdings, Inc. | 76 | $1.62K | 0.00% | +76 | New |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −381,120−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −245,714−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −93,500−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −55,952−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −32,129−100.0% | Sold out |
| Meridian Wealth Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,395−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −12,385−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,110−100.0% | Sold out |